These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 2558539

  • 1. Reduction of ara-C cytotoxicity in HL 60 cells by addition of deoxycytidine, cytidine or increased level of cytidine deaminase.
    Mejer J, Mortensen BT.
    Adv Exp Med Biol; 1989; 253B():335-9. PubMed ID: 2558539
    [No Abstract] [Full Text] [Related]

  • 2. Modulation of the effect of 1-beta-D-arabinofuranosylcytosine based on changes of cytidine deaminase activity in HL60 cells.
    Mejer JN, Mortensen BT, Christensen IJ.
    Med Oncol Tumor Pharmacother; 1990; 7(1):25-9. PubMed ID: 2338846
    [Abstract] [Full Text] [Related]

  • 3. Effect of tetrahydrouridine and deoxytetrahydrouridine on the interaction between 2'-deoxycytidine and 1-beta-D-arabinofuranosylcytosine in human leukemia cells.
    Grant S, Bhalla K, McCrady C.
    Leuk Res; 1991; 15(4):205-13. PubMed ID: 2030601
    [Abstract] [Full Text] [Related]

  • 4. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
    Niitsu N, Ishii Y, Matsuda A, Honma Y.
    Cancer Res; 2001 Jan 01; 61(1):178-85. PubMed ID: 11196157
    [Abstract] [Full Text] [Related]

  • 5. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K, Nayak R, Grant S.
    Cancer Res; 1984 Nov 01; 44(11):5029-37. PubMed ID: 6091869
    [Abstract] [Full Text] [Related]

  • 6. Deoxycytidine kinase and deoxycytidine deaminase values correspond closely to clinical response to cytosine arabinoside remission induction therapy in patients with acute myelogenous leukemia.
    Colly LP, Peters WG, Richel D, Arentsen-Honders MW, Starrenburg CW, Willemze R.
    Semin Oncol; 1987 Jun 01; 14(2 Suppl 1):257-61. PubMed ID: 3035720
    [Abstract] [Full Text] [Related]

  • 7. Studies on mechanisms of resistance to cytosine arabinoside: problems in the determination of related enzyme activities in leukemic cells.
    Coleman CN, Johns DG, Chabner BA.
    Ann N Y Acad Sci; 1975 Aug 08; 255():247-51. PubMed ID: 171992
    [No Abstract] [Full Text] [Related]

  • 8. Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase.
    Bergman AM, Pinedo HM, Jongsma AP, Brouwer M, Ruiz van Haperen VW, Veerman G, Leyva A, Eriksson S, Peters GJ.
    Biochem Pharmacol; 1999 Feb 15; 57(4):397-406. PubMed ID: 9933028
    [Abstract] [Full Text] [Related]

  • 9. The role of deoxycytidine-metabolizing enzymes in the cytotoxicity induced by 3'-amino-2',3'-dideoxycytidine and cytosine arabinoside.
    Mancini WR.
    Cancer Chemother Pharmacol; 1992 Feb 15; 30(2):139-44. PubMed ID: 1318170
    [Abstract] [Full Text] [Related]

  • 10. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
    Katahira R, Ashihara H.
    Planta; 2002 Sep 15; 215(5):821-8. PubMed ID: 12244448
    [Abstract] [Full Text] [Related]

  • 11. Mechanism for ara-CTP catabolism in human leukemic cells and effect of deaminase inhibitors on this process.
    Fridland A, Verhoef V.
    Semin Oncol; 1987 Jun 15; 14(2 Suppl 1):262-8. PubMed ID: 3035721
    [No Abstract] [Full Text] [Related]

  • 12. The impact of selected nucleosides on the cytotoxicity of Ara-C in HL60 cells.
    Mejer J.
    Adv Exp Med Biol; 1991 Jun 15; 309A():97-100. PubMed ID: 1789277
    [No Abstract] [Full Text] [Related]

  • 13. Analysis of cytidine deaminase and tetrahydrouridine interaction by use of ligand techniques.
    Stoller RG, Myers CE, Chabner BA.
    Biochem Pharmacol; 1978 Jan 01; 27(1):53-9. PubMed ID: 619907
    [No Abstract] [Full Text] [Related]

  • 14. Human immunodeficiency virus type 1 induces 1-beta-D-arabinofuranosylcytosine resistance in human H9 cell line.
    Yusa K, Oh-hara T, Tsukahara S, Tsuruo T.
    J Biol Chem; 1992 Aug 25; 267(24):16848-50. PubMed ID: 1512227
    [Abstract] [Full Text] [Related]

  • 15. Deoxycytidine transport in the presence of a cytidine deaminase inhibitor and the transport of uracil in Escherichia coli B.
    von Dippe PJ, Leung K, Roy-Burman S, Visser DW.
    J Biol Chem; 1975 May 25; 250(10):3666-71. PubMed ID: 1092677
    [Abstract] [Full Text] [Related]

  • 16. Enzymology of cytosine arabinoside.
    Cheng YC, Capizzi RL.
    Med Pediatr Oncol; 1982 May 25; 10 Suppl 1():27-31. PubMed ID: 7162464
    [No Abstract] [Full Text] [Related]

  • 17. In vivo development of cytosine arabinoside resistance in the BN acute myelocytic leukemia.
    Hagenbeek A, Martens AC, Colly LP.
    Semin Oncol; 1987 Jun 25; 14(2 Suppl 1):202-6. PubMed ID: 3473677
    [Abstract] [Full Text] [Related]

  • 18. Hemin enhances the sensitivity of erythroleukemia cells to 1-beta-D-arabinofuranosylcytosine by both activation of deoxycytidine kinase and reduction of cytidine deaminase activity.
    Honma Y, Onozuka Y, Okabe-Kado J, Kasukabe T, Hozumi M.
    Cancer Res; 1991 Sep 01; 51(17):4535-8. PubMed ID: 1873797
    [Abstract] [Full Text] [Related]

  • 19. Effect of tetrahydrouridine on metabolism and transport of 1-beta-D-arabinofuranosylcytosine in human cells.
    Riva C, Barra Y, Carcassonne Y, Cano JP, Rustum Y.
    Chemotherapy; 1992 Sep 01; 38(5):358-66. PubMed ID: 1286578
    [Abstract] [Full Text] [Related]

  • 20. Kinetics and substrate specificity of human and canine cytidine deaminase.
    Fanucchi MP, Watanabe KA, Fox JJ, Chou TC.
    Biochem Pharmacol; 1986 Apr 01; 35(7):1199-201. PubMed ID: 3964296
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.